GetTopicDetailResponse(id=d7dd62295e4, topicName=格列本脲, introduction=格列本脲, content=null, image=null, comments=3, allHits=2061, url=https://h5.medsci.cn/topic?id=62295, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=9644, tagList=[TagDto(tagId=9644, tagName=格列本脲)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2200414, encodeId=51a122004143a, content=<a href='/topic/show?id=009488e84d8' target=_blank style='color:#2F92EE;'>#蛛網(wǎng)膜下腔出血#</a> <a href='/topic/show?id=d7dd62295e4' target=_blank style='color:#2F92EE;'>#格列本脲#</a>, objectTitle=【綜述】格列本脲治療蛛網(wǎng)膜下腔出血的研究進(jìn)展, objectType=article, longId=823229, objectId=d872823229c6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=d872823229c6, replyNumber=0, likeNumber=113, createdTime=2024-04-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=d872823229c6, moduleTitle=【綜述】格列本脲治療蛛網(wǎng)膜下腔出血的研究進(jìn)展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d872823229c6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2129770, encodeId=aeb42129e703e, content=<a href='/topic/show?id=ed3e10610883' target=_blank style='color:#2F92EE;'>#地爾硫卓#</a>和<a href='/topic/show?id=d7dd62295e4' target=_blank style='color:#2F92EE;'>#格列本脲#</a>靶向<a href='/topic/show?id=7d2f1061092a' target=_blank style='color:#2F92EE;'>#尿激酶受體#</a>，抑制體內(nèi)<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#腫瘤#</a>的生長(zhǎng)和轉(zhuǎn)移，如果是靶向尿激酶受體，可能的作用是減少轉(zhuǎn)移。
從某種角度上看，尿激酶受體的激活，有助于微循環(huán)。但是，如果抑制了尿激酶受體，可能是短暫抑制了轉(zhuǎn)移，但是從腫瘤本身而言，不一定是有益于治療的。
另外，影響尿激酶受體，可能會(huì)改變<a href='/topic/show?id=f0838291817' target=_blank style='color:#2F92EE;'>#腫瘤微環(huán)境#</a>，有助于<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化療#</a>藥物和<a href='/topic/show?id=a07f82814ec' target=_blank style='color:#2F92EE;'>#腫瘤免疫治療#</a>藥物進(jìn)入腫瘤內(nèi)部，提高療效，這是值得研究的。還有，可能會(huì)減少<a href='/topic/show?id=390810611044' target=_blank style='color:#2F92EE;'>#腫瘤細(xì)胞簇#</a>的形成，這是腫瘤轉(zhuǎn)移的必要條件，以前發(fā)現(xiàn)<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>有這樣的作用。, objectTitle=JMC封面：福州大學(xué)徐芃/李金宇/黃明東等發(fā)現(xiàn)2款老藥可以靶向尿激酶受體，具有抗腫瘤新用途, objectType=article, longId=769833, objectId=1832e698332c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230425/75e7b6514a2a4bbf89029ca18560f940.jpg, objectUrl=/article/show_article.do?id=1832e698332c, replyNumber=0, likeNumber=167, createdTime=2023-05-03, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1832e698332c, moduleTitle=JMC封面：福州大學(xué)徐芃/李金宇/黃明東等發(fā)現(xiàn)2款老藥可以靶向尿激酶受體，具有抗腫瘤新用途, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1832e698332c)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2090266, encodeId=36642090266fe, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲雙胍#</a>通常是T2D的一線治療，并在許多臨床試驗(yàn)中形成基礎(chǔ)治療，這些臨床試驗(yàn)評(píng)估了新的GLD。替代GLD包括鈉-葡萄糖共轉(zhuǎn)運(yùn)體2抑制劑(<a href='/topic/show?id=5c331622ee1' target=_blank style='color:#2F92EE;'>#SGLT2i#</a>)、胰高血糖素樣肽-1受體激動(dòng)劑(GLP-1RA)、二肽基肽酶4抑制劑(<a href='/topic/show?id=03d2622088' target=_blank style='color:#2F92EE;'>#DPP4i#</a>)、<a href='/topic/show?id=2573e388589' target=_blank style='color:#2F92EE;'>#磺脲類藥物#</a>。<a href='/topic/show?id=f8dd10420ed3' target=_blank style='color:#2F92EE;'>#格列齊特#</a>、<a href='/topic/show?id=abae62296da' target=_blank style='color:#2F92EE;'>#格列美脲#</a>、<a href='/topic/show?id=d7dd62295e4' target=_blank style='color:#2F92EE;'>#格列本脲#</a>這些老藥也并不差。<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>, objectTitle=DOM：使用亞洲聯(lián)合糖尿病評(píng)估(JADE)登記系統(tǒng)研究磺脲類藥物在亞洲二型糖尿病患者中的實(shí)際應(yīng)用, objectType=article, longId=740818, objectId=41cee4081830, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/2zKK-712x400.jpg, objectUrl=/article/show_article.do?id=41cee4081830, replyNumber=0, likeNumber=224, createdTime=2022-09-25, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41cee4081830, moduleTitle=DOM：使用亞洲聯(lián)合糖尿病評(píng)估(JADE)登記系統(tǒng)研究磺脲類藥物在亞洲二型糖尿病患者中的實(shí)際應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=41cee4081830)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1240743, encodeId=b5391240e4313, content=<a href='/topic/show?id=d7dd62295e4' target=_blank style='color:#2F92EE;'>#格列本脲#</a>不錯(cuò), objectTitle=格列本脲, objectType=topic, longId=62295, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=121, createdTime=2022-08-24, rootId=0, userName=1e0f3d07m99, userId=36f51942127, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
